Zhejiang Tianyu Pharmaceutical Statistics

Total Valuation

Zhejiang Tianyu Pharmaceutical has a market cap or net worth of CNY 5.53 billion. The enterprise value is 6.75 billion.

Market Cap	5.53B
Enterprise Value	6.75B

Important Dates

The next estimated earnings date is Friday, April 18, 2025.

Earnings Date	Apr 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Zhejiang Tianyu Pharmaceutical has 343.93 million shares outstanding. The number of shares has increased by 1.95% in one year.

Current Share Class	n/a
Shares Outstanding	343.93M
Shares Change (YoY)	+1.95%
Shares Change (QoQ)	-1.95%
Owned by Insiders (%)	56.09%
Owned by Institutions (%)	12.82%
Float	146.98M

Valuation Ratios

The trailing PE ratio is 128.93 and the forward PE ratio is 53.63.

PE Ratio	128.93
Forward PE	53.63
PS Ratio	2.17
PB Ratio	1.57
P/TBV Ratio	1.76
P/FCF Ratio	23.19
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.57, with an EV/FCF ratio of 28.31.

EV / Earnings	154.63
EV / Sales	2.60
EV / EBITDA	15.57
EV / EBIT	72.81
EV / FCF	28.31

Financial Position

The company has a current ratio of 1.15, with a Debt / Equity ratio of 0.49.

Current Ratio	1.15
Quick Ratio	0.40
Debt / Equity	0.49
Debt / EBITDA	3.96
Debt / FCF	7.19
Interest Coverage	1.67

Financial Efficiency

Return on equity (ROE) is 1.24% and return on invested capital (ROIC) is 1.10%.

Return on Equity (ROE)	1.24%
Return on Assets (ROA)	0.91%
Return on Capital (ROIC)	1.10%
Revenue Per Employee	553,203
Profits Per Employee	9,313
Employee Count	4,690
Asset Turnover	0.41
Inventory Turnover	0.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.73% in the last 52 weeks. The beta is -0.01, so Zhejiang Tianyu Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	-0.01
52-Week Price Change	-17.73%
50-Day Moving Average	16.98
200-Day Moving Average	17.03
Relative Strength Index (RSI)	38.00
Average Volume (20 Days)	2,088,821

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Zhejiang Tianyu Pharmaceutical had revenue of CNY 2.59 billion and earned 43.68 million in profits. Earnings per share was 0.12.

Revenue	2.59B
Gross Profit	846.19M
Operating Income	92.77M
Pretax Income	81.79M
Net Income	43.68M
EBITDA	422.24M
EBIT	92.77M
Earnings Per Share (EPS)	0.12

Full Income Statement

Balance Sheet

The company has 495.20 million in cash and 1.72 billion in debt, giving a net cash position of -1.22 billion or -3.55 per share.

Cash & Cash Equivalents	495.20M
Total Debt	1.72B
Net Cash	-1.22B
Net Cash Per Share	-3.55
Equity (Book Value)	3.53B
Book Value Per Share	10.28
Working Capital	390.12M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 425.14 million and capital expenditures -186.53 million, giving a free cash flow of 238.62 million.

Operating Cash Flow	425.14M
Capital Expenditures	-186.53M
Free Cash Flow	238.62M
FCF Per Share	0.69

Full Cash Flow Statement

Margins

Gross margin is 32.61%, with operating and profit margins of 3.58% and 1.68%.

Gross Margin	32.61%
Operating Margin	3.58%
Pretax Margin	3.15%
Profit Margin	1.68%
EBITDA Margin	16.27%
EBIT Margin	3.58%
FCF Margin	9.20%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.32%.

Dividend Per Share	0.05
Dividend Yield	0.32%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	173.08%
Buyback Yield	-1.95%
Shareholder Yield	-1.63%
Earnings Yield	0.78%
FCF Yield	4.31%

Dividend Details

Stock Splits

The last stock split was on June 18, 2021. It was a forward split with a ratio of 1.8.

Last Split Date	Jun 18, 2021
Split Type	Forward
Split Ratio	1.8

Scores

Zhejiang Tianyu Pharmaceutical has an Altman Z-Score of 2.25. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.25
Piotroski F-Score	n/a